))
Advancing the Standard: Gynecologic Cancer Care
Manage episode 505194159 series 3393216
A tartalmat a Baptist Health biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Baptist Health vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
What happens when landmark trials challenge long-standing surgical standards?
In this episode of Doc to Doc, Dr. Thomas Morrissey, director of gynecologic oncology at Lynn Cancer Institute, joins Dr. Ryan Kahn, gynecologic oncologist at Miami Cancer Institute, to explore how data from pivotal studies like TRUST, SHAPE, and MIRASOL are redefining treatment decisions in gynecologic cancer.
From respectability scoring to the evolving role of checkpoint inhibitors and targeted antibody-drug conjugates, this conversation highlights a bold shift toward more personalized, evidence-based care, and what every clinician should know in this new era.
Thomas Morrissey, M.D., Director of Gynecologic Oncology with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital.
Ryan Kahn, M.D.
Gynecologic Oncologist
Baptist Health Miami Cancer Institute
30 epizódok
Megosztás
